IntelliPharmaCeutics International (IntelliPharmaCeutics International) Inventory-to-Revenue : 0.00 (As of Aug. 2023)

View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. IntelliPharmaCeutics International's Average Total Inventories for the quarter that ended in Aug. 2023 was $0.00 Mil. IntelliPharmaCeutics International's Revenue for the three months ended in Aug. 2023 was $0.07 Mil. IntelliPharmaCeutics International's Inventory-to-Revenue for the quarter that ended in Aug. 2023 was 0.00.

IntelliPharmaCeutics International's Inventory-to-Revenue for the quarter that ended in Aug. 2023 stayed the same from May. 2023 (0.00) to May. 2023 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. IntelliPharmaCeutics International's Days Inventory for the three months ended in Aug. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

IntelliPharmaCeutics International Inventory-to-Revenue Historical Data

The historical data trend for IntelliPharmaCeutics International's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Inventory-to-Revenue Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Inventory-to-Revenue

Get a 7-Day Free Trial

0.11

0.09

0.17

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Inventory-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IntelliPharmaCeutics International's Inventory-to-Revenue

For the Biotechnology subindustry, IntelliPharmaCeutics International's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Inventory-to-Revenue falls into.

IntelliPharmaCeutics International Inventory-to-Revenue Calculation

IntelliPharmaCeutics International's Inventory-to-Revenue for the fiscal year that ended in Nov. 2022 is calculated as

	Inventory-to-Revenue (A: Nov. 2022 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Nov. 2021 )	+	Total Inventories (A: Nov. 2022 ))	/	count )	/	Revenue (A: Nov. 2022 )
=	( (0	+	0)	/	1 )	/	0.066
=	0					/	0.066
=	0.00

IntelliPharmaCeutics International's Inventory-to-Revenue for the quarter that ended in Aug. 2023 is calculated as

	Inventory-to-Revenue (Q: Aug. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: May. 2023 )	+	Total Inventories (Q: Aug. 2023 ))	/	count )	/	Revenue (Q: Aug. 2023 )
=	( (0	+	0)	/	1 )	/	0.069
=	0					/	0.069
=	0.00

IntelliPharmaCeutics International (OTCPK:IPCIF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

IntelliPharmaCeutics International's Days Inventory for the three months ended in Aug. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Aug. 2023 )	/	Cost of Goods Sold (Q: Aug. 2023 )	*	Days in Period
	=	0	/	0.018	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

IntelliPharmaCeutics International's Inventory Turnover for the quarter that ended in Aug. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Aug. 2023 )	/	Average Total Inventories (Q: Aug. 2023 )
	=	0.018	/	0
	=

IntelliPharmaCeutics International Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.